Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization EBIAT Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

Ratios

Alto Neuroscience (ANRO) Shares Issued (2023 - 2026)

Alto Neuroscience has reported Shares Issued over the past 4 years, most recently at $6000.0 for Q1 2026.

Quarterly results put Shares Issued at $6000.0 for Q1 2026, down 96.97% from a year ago — trailing twelve months through Mar 2026 was -$192000.0 (down 196.97% YoY), and the annual figure for FY2024 was $137.6 million, up 75910.5%.
Shares Issued reached $6000.0 in Q1 2026 per ANRO's latest filing, up from -$351000.0 in the prior quarter.
Across five years, Shares Issued topped out at $137.6 million in Q1 2024 and bottomed at -$137.5 million in Q2 2024.
Median Shares Issued over the past 4 years was $76000.0 (2023), compared with a mean of $13.8 million.
Peak annual rise in Shares Issued hit 126054.13% in 2024, while the deepest fall reached 319886.05% in 2024.
Over 4 years, Shares Issued stood at $29000.0 in 2023, then surged by 474065.52% to $137.5 million in 2024, then plummeted by 100.26% to -$351000.0 in 2025, then skyrocketed by 101.71% to $6000.0 in 2026.
Business Quant data shows Shares Issued for ANRO at $6000.0 in Q1 2026, -$351000.0 in Q4 2025, and $153000.0 in Q3 2025.